TORONTO, Jan. 28 /CNW/ - DELISTING REVIEW Angiotech Pharmaceuticals, Inc. (the "Company") - TSX is reviewing the Common Shares (Symbol: ANP) of the Company with respect to meeting the requirements for continued
listing pursuant to the Expedited Review Process. The Common Shares are
suspended from trading immediately.
About TMX Group
TMX Group's key subsidiaries operate cash and derivative markets for
multiple asset classes including equities, fixed income and energy.
Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange,
Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom
and other TMX Group companies provide trading markets, clearing
facilities, data products and other services to the global financial
community. TMX Group is headquartered in Toronto with offices in
Montreal, Calgary and Vancouver. For more information about TMX Group,
visit our website at www.tmx.com.
SOURCE TMX GROUP INC.
For further information:
Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, email@example.com.